Balyasny Asset Management
TYRA icon

Balyasny Asset Management’s Tyra Biosciences TYRA Stock Holding History

Balyasny Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5M Sell
351,479
-466,847
-57% -$15.1M 0.02% 876
2025
Q4 		$21.5M Sell
818,326
-28,259
-3% -$519K 0.03% 674
2025
Q3 		$11.8M Buy
846,585
+263,199
+45% +$3M 0.02% 969
2025
Q2 		$5.58M Buy
583,386
+340,142
+140% +$3.23M 0.01% 1235
2025
Q1 		$2.26M Buy
+243,244
New +$3.15M ﹤0.01% 1653
2024
Q4 		– Sell
-12,988
Closed -$305K – 3275
2024
Q3 		$305K Buy
+12,988
New +$273K ﹤0.01% 2453

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Balyasny Asset Management's TYRA Position: Q1 2026 in Review

Balyasny Asset Management reduced its Tyra Biosciences (TYRA) stake by 57% in Q1 2026, selling an estimated $15.1M and leaving 351,479 shares worth $13.5M. The position accounts for 0.02% of the portfolio, ranked #876.

Balyasny Asset Management first reported a position in TYRA in Q3 2024 and has held it in 6 quarters since. The position peaked at $21.5M in Q4 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Balyasny Asset Management held 351,479 shares of Tyra Biosciences worth $13.5M as of Q1 2026.
  • Balyasny Asset Management sold 466,847 Tyra Biosciences shares in Q1 2026, an estimated $15.1M.
  • Tyra Biosciences made up 0.02% of Balyasny Asset Management's portfolio in Q1 2026, its #876 holding.
  • Balyasny Asset Management first reported a position in Tyra Biosciences in Q3 2024 and has held it in 6 quarters since.
  • Balyasny Asset Management's Tyra Biosciences position peaked at $21.5M in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.